Miltenyi Biotec Unveils India's 1st Cell & Gene Therapy CoE in Hyderabad
The Miltenyi Innovation and Technology Centre (MITC) is equipped with advanced MACS instruments and the CliniMACS Prodigy platform, which will support therapy development and manufacturing.
Miltenyi Biotec has inaugurated India's first dedicated center of excellence for cell and gene therapy in Hyderabad, marking a significant development in the country's life sciences landscape.
The Miltenyi Innovation and Technology Centre (MITC) is equipped with advanced MACS instruments and the CliniMACS Prodigy platform, which will support therapy development and manufacturing.
It is designed to facilitate collaboration through seminars and workshops focused on immunology, stem cell biology, and cancer research, addressing key areas in the fight against disease.
The inauguration ceremony was attended by D Sridhar Babu, Minister for Industries and IT, and Dr Kathrin Misera-Lang, Consul General (interim) of the Federal Republic of Germany in Chennai, along with other notable figures from the industry.
D Sridhar Babu, IT and Industries Minister of Telangana emphasised, "This facility strengthens our healthcare ecosystem and supports our vision of making Telangana a global leader in advanced biotechnology and healthcare solutions, particularly in cell and gene therapies."
Located in Genome Valley, the facility spans 1,800 square meters and aims to foster innovation in biotechnological advancements.
Dr Boris Stoffel, Chief Commercial Officer, Member of the Board, Miltenyi Biotec B.V. & Co. KG, said, "MITC will drive advancements in biomedical research, supporting the scientific and medical community in developing new therapies for diseases with limited treatment options. It will enable close collaboration with researchers, physicians and industry providing them with the tools and expertise needed to deliver transformative therapies to patients."
